BlackRock Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $25K | Hold |
3,246
| – | – | ﹤0.01% | 2944 |
|
|
2016
Q3 | $37K | Hold |
3,246
| – | – | ﹤0.01% | 2932 |
|
|
2016
Q2 | $40K | Hold |
3,246
| – | – | ﹤0.01% | 2939 |
|
|
2016
Q1 | $33K | Buy |
3,246
+2,347
| +261% | +$23.9K | ﹤0.01% | 2974 |
|
|
2015
Q4 | $20K | Hold |
899
| – | – | ﹤0.01% | 2935 |
|
|
2015
Q3 | $15K | Buy |
+899
| New | +$15K | ﹤0.01% | 2992 |
|
|
2015
Q2 | – | Sell |
-243
| Closed | -$6K | – | 2993 |
|
|
2015
Q1 | $6K | Hold |
243
| – | – | ﹤0.01% | 2826 |
|
|
2014
Q4 | $5K | Hold |
243
| – | – | ﹤0.01% | 2857 |
|
|
2014
Q3 | $5K | Sell |
243
-6,138
| -96% | -$126K | ﹤0.01% | 2807 |
|
|
2014
Q2 | $149K | Buy |
+6,381
| New | +$149K | ﹤0.01% | 2503 |
|
|
2013
Q4 | – | Sell |
-5,919
| Closed | -$91K | – | 2954 |
|
|
2013
Q3 | $91K | Buy |
+5,919
| New | +$91K | ﹤0.01% | 2605 |
|